For patients |
Provide better biomarker based diagnostic and prognostic evaluation |
Improve acceptability of stage (terminology) |
For health care professionals: |
Improve and consolidate the criteria for diagnosis of APD among clinicians providing standardised criteria |
Develop specific pathways which engage movement disorder specialists/“parkinsonologists” so that appropriate guidance for management is initiated early including multidisciplinary services |
Provide guidance for appropriate and timely implementation of advanced therapeutic options |
Develop appropriate toolkits and scales |
For health care providers |
Early evaluation of relevant datasets in appropriate group of patients when described as advanced therapies |
Facilitate early reimbursement of therapies with reasonable evidence base in appropriate patient groups |
Define APD in WHO ICD coding handbook |
For developing a true holistic concept |
Improve patient care and carer quality of life (affected by the term “advanced” with implications on lifestyle, prognosis as well as social interaction) |